The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of formula (I)
wherein R
1
, R
2
and R
3
are as defined in the specification. These compounds are useful for the treatment of CNS disorders.
PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS
申请人:F. Hoffmann-La Roche AG
公开号:EP1858862B1
公开(公告)日:2016-04-20
US7947685B2
申请人:——
公开号:US7947685B2
公开(公告)日:2011-05-24
[EN] PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS<br/>[FR] DÉRIVÉS DE PYRAZINE-2-CARBOXAMIDE EN TANT QU'ANTAGONISTES DU MGLUR5
申请人:HOFFMANN LA ROCHE
公开号:WO2006094691A1
公开(公告)日:2006-09-14
[EN] The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of the general formula (I) useful as metabotropic glutamate receptor antagonists: formula (I) wherein R1, R2 and R3 are as defined in the description and claims. [FR] La présente invention concerne de nouveaux dérivés de pyrazine-2-carboxyamide de la formule générale (I), utiles en tant qu'antagonistes de récepteurs métabotropiques de glutamate : formule (I) où R1, R2 et R3 sont tels que définis dans la description et les revendications.
Pyrazine-2-carboxyamide derivatives
申请人:Jaeschke Georg
公开号:US20060199828A1
公开(公告)日:2006-09-07
The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of formula (I)
wherein R
1
, R
2
and R
3
are as defined in the specification. These compounds are useful for the treatment of CNS disorders.